APA (7th ed.) Citation

A, J., G, B., IW, d. P., T, G., RA, d. F., B, S., . . . D, M. (2016). A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 20(6), 832. https://doi.org/10.5588/ijtld.15.0577

Chicago Style (17th ed.) Citation

A, Jindani, et al. "A Randomised Phase II Trial to Evaluate the Toxicity of High-dose Rifampicin to Treat Pulmonary Tuberculosis." The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union Against Tuberculosis and Lung Disease 20, no. 6 (2016): 832. https://doi.org/10.5588/ijtld.15.0577.

MLA (9th ed.) Citation

A, Jindani, et al. "A Randomised Phase II Trial to Evaluate the Toxicity of High-dose Rifampicin to Treat Pulmonary Tuberculosis." The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union Against Tuberculosis and Lung Disease, vol. 20, no. 6, 2016, p. 832, https://doi.org/10.5588/ijtld.15.0577.